Newsroom | 34335 results

Sorted by: Latest

Oncology
-

Curebound Cancer Challenge Raises $4 Million to Fund Vital Research in San Diego

SAN DIEGO--(BUSINESS WIRE)--Curebound Cancer Challenge generates outpouring of community support, raising $4 million to advance life-saving cancer research in San Diego region....
-

AI in Medical Imaging: From Experimentation to Operation - Market Projections & Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "World Market for AI in Medical Imaging 2025-2032" report has been added to ResearchAndMarkets.com's offering. Radiology faces a triple squeeze: rising scan volumes, stagnant radiologist head-count, and fast-evolving reimbursement that now rewards computer-assisted detection, triage, and quantification. AI is no longer experimental; it is operational. Capital allocation is shifting, yet market signals remain noisy - valuations, attach-rate assumptions, and regulator...
-

Susan G. Komen® MORE THAN PINK Walk Returns to Georgia This October

ATLANTA--(BUSINESS WIRE)--Susan G. Komen®, the world’s leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the 2025 Georgia MORE THAN PINK Walk. This impactful event unites our community and raises money for the mission of Komen. Komen aims to raise $805K at the Georgia MORE THAN PINK Walk, generating critical funds that allow Komen to continue its investment in lifesaving work across the country, including...
-

TAE Life Sciences and University of Wisconsin-Madison to Bring Promising Accelerator-Based BNCT Cancer Treatment to the USA

IRVINE, Calif.--(BUSINESS WIRE)--TAE Life Sciences (TLS), a global leader in advancing next-generation boron neutron capture therapy (BNCT), and the University of Wisconsin–Madison (UW) have signed a memorandum of understanding (MOU) announcing the intention to launch the first accelerator-based BNCT center in the United States. As part of this collaboration, UW would install the Alphabeam compact accelerator-based BNCT system developed by TAE Life Sciences. This significant milestone has the p...
-

GE HealthCare debuts AI-supported solution, designed to improve and shorten the radiation therapy workflow, at ASTRO 2025

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced updates to Intelligent Radiation Therapy (iRT), a new version of the company’s software solution for radiation therapy workflow management, designed to reduce the time it takes for patients to go from diagnosis to treatment. The iRT solution is AI-supported by GE HealthCare and third-party applications, and the latest features bring enhanced connectivity to the systems radiation oncology departments use most and use insights...
-

Integrated DNA Technologies Launches New Enhancer Protein to Accelerate CRISPR-Based Therapies from Translational Research to Clinical Breakthrough

CORALVILLE, Iowa--(BUSINESS WIRE)--New enhancer protein expands IDT's market-leading portfolio of HDR reagents, empowering cell and gene therapy developers to accelerate discoveries...
-

National Cancer Center Announces Recipients of 2025-26 Research Fellowship Awards

NEW YORK--(BUSINESS WIRE)--NCC Announces Recipients of 2025-26 Research Fellowship Awards...
-

Katie Couric Joins the Colorectal Cancer Alliance to ‘LEAD FROM BEHIND’

WASHINGTON--(BUSINESS WIRE)--To commemorate the 25th anniversary of sharing her colonoscopy on TODAY, Katie Couric is teaming up with the nation’s leading nonprofit dedicated to ending colon cancer, the Colorectal Cancer Alliance (Alliance), and Ryan Reynolds’ entertainment company, Maximum Effort, to LEAD FROM BEHIND. LEAD FROM BEHIND is a series of entertaining videos featuring celebrities breaking the stigma surrounding colon cancer to spark conversations about screening for The Preventable...
-

STREAM Consortium and Inocras Unveil Landmark National Pediatric Cancer WGS Program, funded by the Lee Kun-hee Child Cancer and Rare Disease Project

SAN DIEGO & BOSTON--(BUSINESS WIRE)--Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights that advance precision health, in collaboration with the Lee Kun-hee Child Cancer and Rare Disease Project, today announced results from the STREAM Program (Strategic TREatment And Magic for pediatric cancers). The project, established through a donation from the family of the late Samsung Chairman Lee Kun-hee, is the first na...
-

Circle Pharma Announces Poster Presentation Highlighting the Potential of CID-078, a First-in-class Oral Cyclin A/B RxL Inhibitor, at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer

SAN FRANCISCO--(BUSINESS WIRE)--Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced an upcoming poster presentation highlighting the potential of CID-078 as a novel therapeutic option in pediatric cancers at the American Association for Cancer Research (AACR) Special Conference on Pediatric Cancer, taking place from September 25-28 in Boston, MA. CID-078 is a first-in-class, orally bioavailable m...